Evaluation of Silk Biomaterials in Combination with Extracellular Matrix Coatings for Bladder Tissue Engineering with Primary and Pluripotent Cells

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Franck, Debra ^a   Gil, Eun Seok ^c   Adam, Rosalyn M ^a,b   Kaplan, David L ^c   Chung, Yeun Goo ^a   Estrada, Carlos R ^a,b   Mauney, Joshua R ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Tufts University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; COLLAGEN TYPE 1; COLLAGEN TYPE 4; CONTRACTILE PROTEIN; CYTOKERATIN; FIBRONECTIN; MESSENGER RNA; RETINOIC ACID; SILK; TISSUE SCAFFOLD; TRANSFORMING GROWTH FACTOR BETA1; TRANSGELIN; UROPLAKIN;

ANIMAL CELL; ARTICLE; BLADDER MUSCLE; CELL ADHESION; CELL DIFFERENTIATION; CELL LINEAGE; CELL POPULATION; CELL PROLIFERATION; COATED PARTICLE; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; EVALUATION RESEARCH; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MATERIAL COATING; MATERIALS TESTING; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; POROSITY; PROTEIN EXPRESSION; SMOOTH MUSCLE CONTRACTILITY; TISSUE ENGINEERING; UPREGULATION;

EID: 84873604209     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056237     Document Type: Article

References (47)

1. Atala A, (2000) Tissue engineering for bladder substitution. World J Urol 18: 364-370.
2. Hensle TW, Gilbert SM, (2007) A review of metabolic consequences and long-term complications of enterocystoplasty in children. Curr Urol Rep 8: 157-162.
3. Atala A, (2011) Tissue engineering of human bladder. Br Med Bull 97: 81-104.
4. Kropp BP, (1998) Small-intestinal submucosa for bladder augmentation: a review of preclinical studies. World J Urol 16: 262-267.
5. Oberpenning F, Meng J, Yoo JJ, Atala A, (1999) De novo reconstitution of a functional mammalian urinary bladder by tissue engineering. Nat Biotechnol 17: 149-155.
6. Zhu WD, Xu YM, Feng C, Fu Q, Song LJ, (2011) Different bladder defects reconstructed with bladder acellular matrix grafts in a rabbit model. Urologe A 50: 1420-1425.
7. Atala A, Bauer SB, Soker S, Yoo JJ, Retik AB, (2006) Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 367: 1241-1246.
8. Caione P, Boldrini R, Salerno A, Nappo SG, (2012) Bladder augmentation using acellular collagen biomatrix: a pilot experience in exstrophic patients. Pediatr Surg Int 28: 421-428.
9. Kanematsu A, Yamamoto S, Noguchi T, Ozeki M, Tabata Y, et al. (2003) Bladder regeneration by bladder acellular matrix combined with sustained release of exogenous growth factor. J Urol 170: 1633-1638.
10. Ceonzo K, Gaynor A, Shaffer L, Kojima K, Vacanti CA, et al. (2006) Polyglycolic acid-induced inflammation: role of hydrolysis and resulting complement activation. Tissue Eng 12: 301-308.
11. Zhang Y, Frimberger D, Cheng EY, Lin HK, Kropp BP, (2006) Challenges in a larger bladder replacement with cell-seeded and unseeded small intestinal submucosa grafts in a subtotal cystectomy model. BJU Int 98: 1100-1105.
12. Kim UJ, Park J, Kim HJ, Wada M, Kaplan DL, (2005) Three-dimensional aqueous-derived biomaterial scaffolds from silk fibroin. Biomaterials 26: 2775-2785.
13. Altman GH, Diaz F, Jakuba C, Calabro T, Horan RL, et al. (2003) Silk-based biomaterials. Biomaterials 24: 401-416.
14. Wang Y, Rudym DD, Walsh A, Abrahamsen L, Kim HJ, et al. (2008) In vivo degradation of three-dimensional silk fibroin scaffolds. Biomaterials 29: 3415-3428.
15. Lovett ML, Cannizzaro CM, Vunjak-Novakovic G, Kaplan DL, (2008) Gel spinning of silk tubes for tissue engineering. Biomaterials 29: 4650-4657.
16. Mauney JR, Cannon GM, Lovett ML, Gong EM, Di Vizio D, et al. (2011) Evaluation of gel spun silk-based biomaterials in a murine model of bladder augmentation. Biomaterials 32: 808-818.
17. Gomez P, Gil ES, Lovett ML, Rockwood DN, Di Vizio D, et al. (2011) The effect of manipulation of silk scaffold fabrication parameters on matrix performance in a murine model of bladder augmentation. Biomaterials 32: 7562-7570.
18. Brown AL, Farhat W, Merguerian PA, Wilson GJ, Khoury AE, et al. (2001) 22 week assessment of bladder acellular matrix as a bladder augmentation material in a porcine model. Biomaterials 23: 2179-2190.
19. Akbal C, Lee SD, Packer SC, Davis MM, Rink RC, et al. (2006) Bladder augmentation with acellular dermal biomatrix in a diseased animal model. J Urol 176: 1706-1711.
20. Hipp JA, Hipp JD, Yoo JJ, Atala A, Andersson KE, (2008) Microarray analysis of bladder smooth muscle from patients with myelomeningocele. BJU Int 102: 741-746.
21. Subramaniam R, Hinley J, Stahlschmidt J, Southgate J, (2011) Tissue engineering potential of urothelial cells from diseased bladders. J Urol 186: 2014-2020.
22. Jack GS, Zhang R, Lee M, Xu Y, Wu BM, et al. (2009) Urinary bladder smooth muscle engineered from adipose stem cells and a three dimensional synthetic composite. Biomaterials 30: 3259-3270.
23. Sharma AK, Bury MI, Marks AJ, Fuller NJ, Meisner JW, et al. (2011) A Non-Human Primate Model for Urinary Bladder Regeneration Utilizing Autologous Sources of Bone Marrow Derived Mesenchymal Stem Cells. Stem Cells 29: 241-250.
24. Tian H, Bharadwaj S, Liu Y, Ma PX, Atala A, et al. (2010) Differentiation of human bone marrow mesenchymal stem cells into bladder cells: potential for urological tissue engineering. Tissue Eng Part A 16: 1769-1779.
25. Ning J, Li C, Li H, Chang J, (2011) Bone marrow mesenchymal stem cells differentiate into urothelial cells and the implications for reconstructing urinary bladder mucosa. Cytotechnology 63: 531-539.
26. Hwang WS, Lee BC, Lee CK, Kang SK, (2005) Cloned human embryonic stem cells for tissue repair and transplantation. Stem Cell Rev 1: 99-109.
27. Takahashi K, Yamanaka S, (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
28. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872.
29. Mauney JR, Kaplan DL, Volloch V, (2004) Matrix-mediated retention of osteogenic differentiation potential by human adult bone marrow stromal cells during ex vivo expansion. Biomaterials 25: 3233-3243.
30. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, et al. (1998) Embryonic stem cell lines derived from human blastocysts. Science 282: 1145-1147.
31. Rooney GE, Nistor GI, Barry FB, Keirstead HS, (2010) In vitro differentiation potential of human embryonic versus adult stem cells. Regen Med 5: 365-379.
32. Mauney JR, Ramachandran A, Yu RN, Daley GQ, Adam RM, et al. (2010) All-trans Retinoic acid Directs Urothelial Specification of Murine Embryonic Stem Cells via GATA4/6 Signaling Mechanisms. PLoS ONE 5: e11513.
33. Xie CQ, Huang H, Wei S, Song LS, Zhang J, et al. (2009) A comparison of murine smooth muscle cells generated from embryonic versus induced pluripotent stem cells. Stem Cells Dev 18: 741-748.
34. Chen J, Altman GH, Karageorgiou V, Horan R, Collette A, et al. (2003) Human bone marrow stromal cell and ligament fibroblast responses on RGD-modified silk fibers. J Biomed Mater Res A 67: 559-570.
35. Garcia-Fuentes M, Meinel AJ, Hilbe M, Meinel L, Merkle HP, (2009) Silk fibroin/hyaluronan scaffolds for human mesenchymal stem cell culture in tissue engineering. Biomaterials 30: 5068-5076.
36. Kim J, Mihee J, DiDonato J, Rackley R, Kuang M, et al. (2011) An hTERT-Immortalized Human Urothelial Cell Line that Responds to Anti-Proliferative Factor. In Vitro Cell Dev Biol Anim 47: 2-9.
37. Chomczynski P, Sacchi N, (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159.
38. Huang H, Zhao X, Chen L, Xu C, Yao X, et al. (2006) Differentiation of human embryonic stem cells into smooth muscle cells in adherent monolayer culture. Biochem Biophys Res Commun 351: 321-327.
39. Wu XR, Kong XP, Pellicer A, Kreibich G, Sun TT, (2009) Uroplakins in urothelial biology, function, and disease. Kidney Int 75: 1153-1165.
40. Woodman JR, Mansfield KJ, Lazzaro VA, Lynch W, Burcher E, et al. (2011) Immunocytochemical characterisation of cultures of human bladder mucosal cells. BMC Urol 11: 5 doi:10.1186/1471-2490-11-5.
41. Wilson CB, Leopard J, Cheresh DA, Nakamura RM, (1996) Extracellular matrix and integrin composition of the normal bladder wall. World J Urol 14: S30-S37.
42. Choudhary S, Berhe M, Haberstroh KM, Webster TJ, (2006) Increased endothelial and vascular smooth muscle cell adhesion on nanostructured titanium and CoCrMo. Int J Nanomedicine 1: 41-49.
43. Baker SC, Southgate J, (2008) Towards control of smooth muscle cell differentiation in synthetic 3D scaffolds. Biomaterials 29: 3357-3366.
44. Kaimoto T, Yasuda O, Ohishi M, Mogi M, Takemura Y, et al. (2010) Nifedipine inhibits vascular smooth muscle cell dedifferentiation via downregulation of Akt signaling. Hypertension 56: 247-252.
45. Chun YW, Khang D, Haberstroh KM, Webster TJ, (2009) The role of polymer nanosurface roughness and submicron pores in improving bladder urothelial cell density and inhibiting calcium oxalate stone formation. Nanotechnology 20: 085104 doi:10.1088/0957-4484/20/8/085104.
46. Micallef SJ, Janes ME, Knezevic K, Davis RP, Elefanty AG, et al. (2005) Retinoic acid induces Pdx1-positive endoderm in differentiating mouse embryonic stem cells. Diabetes 54: 301-305.
47. Metallo CM, Ji L, de Pablo JJ, Palecek SP, (2008) Retinoic acid and bone morphogenetic protein signaling synergize to efficiently direct epithelial differentiation of human embryonic stem cells. Stem Cells 26: 372-380.